Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Thyroid Diseases × tomivosertib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1 Dermatologic 1

Conditions

Thyroid Diseases 1 Neoplasms 1 Melanoma 1 Lymphoma 1

Interventions

selpercatinib 2 tomivosertib 1 repotrectinib 1 pralsetinib 1 NAc-Sar-Gly-Val-(d-allo-Ile)-Thr-Nva-Ile-Arg-ProNEt 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02605083 2020-11-02

A Dose Escalation and Cohort-Expansion Study of Oral eFT508 in Subjects With Advanced Solid Tumors

Effector Therapeutics

Phase 1/2 Terminated

DermatologicHead & Neck

Melanoma, Neoplasms, Thyroid Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡